Stocks
Invest in Stocks
Invest in stocks, ETFs, IPOs with fast orders. Track returns on your stock holdings and view real-time P&L on your positions.
F&O
Create Stock SIPAutomate your investments in this
Performance
Open
463.00Prev. Close
470.05Volume
6,876Total traded value
0.32 CrUpper Circuit
552.10Lower Circuit
368.10Fundamentals
| Market Cap | ₹3,243Cr |
| ROE | 5.61% |
| P/E Ratio(TTM) | 25.95 |
| EPS(TTM) | 17.75 |
| P/B Ratio | 1.32 |
| Dividend Yield | 0.00% |
| Industry P/E | 33.92 |
| Book Value | 348.07 |
| Debt to Equity | 0.19 |
| Face Value | 2 |
Understand Fundamentals
Financials
About Unichem Laboratories
Unichem Laboratories is a global pharmaceutical company that manufactures Active Pharmaceutical Ingredients (APIs) and a wide range of finished drug formulations for international markets. It is driven by a commitment to quality and excellence, aiming to surpass stringent global manufacturing standards required for business in regulated markets. Demonstrating significant operational growth, its formulation output increased by 52%, reaching 15.17 billion tablets and capsules in the financial year 2025.;
| Parent Organisation | Unichem Laboratories |
| Managing Director | Mr. Pabitrakumar Bhattacharyya |
| NSE Symbol | UNICHEMLAB |
Shareholding Pattern
Sep '24
Dec '24
Mar '25
Jun '25
Sep '25
Top Mutual Funds Invested(2)
| FUND NAME | AUM(%) |
|---|---|
| DSP Healthcare Fund Direct Growth | 1.28% |
| HDFC Small Cap Fund Direct Growth | 0.68% |
Similar Stocks
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Cohance Lifesciences | NA (0.00%) | 82.27 | ||
| JB Chemicals & Pharmaceuticals | NA (0.00%) | 38.89 | ||
| Emcure Pharmaceuticals | NA (0.00%) | 33.53 | ||
| Wockhardt | NA (0.00%) | -426.40 |